PD07
PD07 is an orally active AChE inhibitor (IC50: 0.29 μM for hAChE). PD07 also inhibits ChEs, BACE1 (IC50: 13.42 μM), and Aβ1–42 aggregation in in vitro. PD07 is an antioxidant, and shows DPPH inhibitory activity (IC50: 26.46 μM). PD07 improves memory and cognition in Scopolamine -induced amnesia rats. PD07 can be used for research of Alzheimer’s disease[1].
Product Specifications
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pd07.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(C(N2CCN(C(/C=C/C=C/C3=CC(OCO4)=C4C=C3)=O)CC2)=O)C=C1
Molecular Formula
C23H21ClN2O4
Molecular Weight
424.88
References & Citations
[1]Bhanukiran K, et al. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease. ACS Chem Neurosci. 2023 Aug 2;14 (15) :2743-2760.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N5375-51H-Biotin 100 µL
NOTCH4 (Neurogenic Locus Notch Homolog Protein 4, Notch 4, hNotch4, INT3) (Biotin) discontinued
Sign In for Pricing
View Details 38358141 1x 10^6 Cells / 1.0 mL
RAB6B CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details MBS6361114-01 0.2 mL
UGCGL1, CT (UGGT1, GT, UGCGL1, UGGT, UGT1, UGTR, UDP-glucose:glycoprotein glucosyltransferase 1, UDP-Glc:glycoprotein glucosyltransferase, UDP-glucose ceramide glucosyltransferase-like 1) (APC)
Sign In for Pricing
View Details